Obesity News

Last year, researchers reported that the prevalence of pediatric obesity increased to 21% in the United States between 2011 and 2020.

Adhering to a vegan diet led to a significant decrease in total food costs per day for those with overweight, according to the results of research published in JAMA Network Open.

CV deaths related to obesity increased by 200% across all race groups from 1999 to 2020, a statistic researchers said reflects the health consequences of the rising burden of obesity in the United States.

Last year, the CDC updated its 22-year-old pediatric BMI-for-age growth charts to add BMIs above the 97th percentile for the first time in order to track severe obesity in children aged 2 to 19 years.

Researchers estimated that semaglutide could cut the obesity prevalence in the United States by about 46% and prevent more than 1.5 million CVD events over 10 years when given to eligible patients with overweight or obesity.

Recent reports in the media and legal action have raised questions about the safety of popular weight-loss drugs, particularly about whether they increase the risk for events such as gastroparesis and gastroenteritis.

In adults with HF with preserved ejection fraction and obesity, semaglutide 2.4 mg significantly improved HF-related symptoms and physical limitations and was associated with greater weight loss compared with placebo, researchers reported.

Beyond obesity's association with cardiovascular diseases and metabolic disorders, mounting evidence reveals a deep-rooted connection between obesity and cancer risk.

Adults with overweight or obesity had a 10% annual probability of achieving 5% or greater weight loss, according to study data published in JAMA Network Open.

A 10-year intensive lifestyle intervention designed for weight loss in those with type 2 diabetes and overweight/obesity was tied to significantly higher employment levels compared with diabetes education alone, according to researchers.